{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:42:46Z","timestamp":1788090166943,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109252","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:56:34Z","timestamp":1779263794000},"source":"Crossref","is-referenced-by-count":1,"title":["Tuberculous Miliary Disease Following Intravesical Bacillus Calmette-Gu\u00e9rin Therapy for Urothelial Carcinoma of the Bladder: A Case Report"],"prefix":"10.7759","author":[{"given":"Achraf","family":"Benamou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouar","family":"El Moudane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Barki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales A","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976, 116:180-3. 10.1016\/s0022-5347(17)58737-6","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer-a current perspective","volume":"11","author":"Redelman-Sidi G","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer-a current perspective. Nat Rev Urol. 2014, 11:153-62. 10.1038\/nrurol.2014.15","journal-title":"Nat Rev Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.07.021","article-title":"Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG","volume":"65","author":"Brausi M","year":"2014","unstructured":"Brausi M, Oddens J, Sylvester R, et al.. Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 2014, 65:69-76. 10.1016\/j.eururo.2013.07.021","journal-title":"Eur Urol"},{"key":"ref4","article-title":"Complications of Bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"19","author":"Lamm DL","year":"1992","unstructured":"Lamm DL. Complications of Bacillus Calmette-Gu\u00e9rin immunotherapy. Urol Clin North Am. 1992, 19:565-72.","journal-title":"Urol Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1086\/344908","article-title":"Spectrum of Bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez OY","year":"2003","unstructured":"Gonzalez OY, Musher DM, Brar I, et al.. Spectrum of Bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis. 2003, 36:140-8. 10.1086\/344908","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.11.037","article-title":"BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: a systematic review","volume":"39","author":"Cabas P","year":"2021","unstructured":"Cabas P, Rizzo M, Giuffr\u00e8 M, et al.. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: a systematic review. Urol Oncol. 2021, 39:85-92. 10.1016\/j.urolonc.2020.11.037","journal-title":"Urol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019180014","article-title":"Complications of intravesical BCG immunotherapy for bladder cancer","volume":"39","author":"Green DB","year":"2019","unstructured":"Green DB, Kawashima A, Menias CO, et al.. Complications of intravesical BCG immunotherapy for bladder cancer. Radiographics. 2019, 39:80-94. 10.1148\/rg.2019180014","journal-title":"Radiographics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2019.10.001","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review","volume":"26","author":"Marques M","year":"2020","unstructured":"Marques M, Vazquez D, Sousa S, Mesquita G, Duarte M, Ferreira R. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review. Pulmonology. 2020, 26:346-52. 10.1016\/j.pulmoe.2019.10.001","journal-title":"Pulmonology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3343\/kjlm.2011.31.3.197","article-title":"Mycobacterial infection after intravesical Bacillus Calmette-Gu\u00ebrin treatment for bladder cancer: a case report","volume":"31","author":"Park CH","year":"2011","unstructured":"Park CH, Jang MA, Ahn YH, Hwang YY, Ki CS, Lee NY. Mycobacterial infection after intravesical Bacillus Calmette-Gu\u00ebrin treatment for bladder cancer: a case report. Korean J Lab Med. 2011, 31:197-200. 10.3343\/kjlm.2011.31.3.197","journal-title":"Korean J Lab Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2020.100149","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) treatment's severe complications: a single institution review of incidence, presentation and treatment outcome","volume":"19","author":"Waked R","year":"2020","unstructured":"Waked R, Choucair J, Chehata N, Haddad E, Saliba G. Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) treatment's severe complications: a single institution review of incidence, presentation and treatment outcome. J Clin Tuberc Other Mycobact Dis. 2020, 19:100149. 10.1016\/j.jctube.2020.100149","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.07.076","article-title":"A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group","volume":"186","author":"Brausi M","year":"2011","unstructured":"Brausi M, Witjes JA, Lamm D, et al.. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol. 2011, 186:2158-67. 10.1016\/j.juro.2011.07.076","journal-title":"J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6230409","article-title":"Clinical spectrum of complications induced by intravesical immunotherapy of Bacillus Calmette-Gu\u00e9rin for bladder cancer","volume":"2019","author":"Liu Y","year":"2019","unstructured":"Liu Y, Lu J, Huang Y, Ma L. Clinical spectrum of complications induced by intravesical immunotherapy of Bacillus Calmette-Gu\u00e9rin for bladder cancer. J Oncol. 2019, 2019:6230409. 10.1155\/2019\/6230409","journal-title":"J Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464257-tuberculous-miliary-disease-following-intravesical-bacillus-calmette-gurin-therapy-for-urothelial-carcinoma-of-the-bladder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:56:35Z","timestamp":1779263795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464257-tuberculous-miliary-disease-following-intravesical-bacillus-calmette-gurin-therapy-for-urothelial-carcinoma-of-the-bladder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.109252","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}